News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
Mayo Clinic is the largest integrated transplant provider in the United States. Mayo Clinic has pre-eminent adult and pediatric transplant programs, offering heart, liver, kidney, pancreas, lung, hand, face, and blood and bone marrow transplant services. Mayo doctors performed their first clinical transplant in 1963.
Regenerative medicine
..(Researchers also study and test how reprogrammed stem cells may be turned into specialized cells that can repair or regenerate cells in your heart, blood, nerves and other parts of your body. These stem cells have the potential to treat many conditions. Stem cells also may be studied to understand how other conditions occur, to develop and test new medications, and for other research)
U.S. News & World Report has named Mayo Clinic to its annual list of "Best Hospitals" for more than 20 years.
https://www.mayoclinic.org/departments-centers/transplant-center/sections/expertise-ranking/orc-20203899
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
$LAHO GSCG FUTURE OF MEDICINE$$$$$$$$$$$$
$LAHO .GSCG will also be hosting the International Cell Therapy Symposium on the University of Miami campus in Miami, Florida on October 24, 2019. The event is expected to draw a large attendance of physicians in the regenerative medicine field, and the GSCG has invited more than 10 scientists and practitioners with vast experience in regenerative medicine to host the congress’ educational sessions. At least five of the conference sessions will focus on how exosomes can help people suffering from degenerative diseases
http://www.prunderground.com/adimarket-set-to-share-innovative-exosomes-products-at-upcoming-medical-congresses-2/00165031/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150860063
Doctors and scientists are excited about stem cells because they could help in many different areas of health and medical research. Studying stem cells may help explain how serious conditions such as birth defects and cancer come about. Stem cells may one day be used to make cells and tissues for therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis.
https://medlineplus.gov/
..The FDA acknowledges the potential of stem cell therapy but warns patients hoping for yet unavailable cures are vulnerable to unscrupulous providers.
It isn’t about “living forever” which strikes Hariri’s engineering brain as a rather vague notion. It’s about living a full life with the extra years modern medicine has given us.
“[If we can do it] in orthopedics, it’ll maintain a level of mobility that we’ve never seen before. If we can do it in the brain; if we can do it in the heart; if we can do it in other organ systems, I think that’s the key to living to 100 and being as active at 95 as you were at 45.”
https://singularityhub.com/2017/11/10/the-dream-of-regenerative-medicine-is-alive-and-well/
Stem Cell Transplants in Cancer Treatment
Stem cell transplants help restore blood-forming stem cells in people who have had theirs destroyed by certain cancer treatments.
Credit: National Cancer Institute
Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant
6 “firsts” in advancing regenerative medicine toward patient care
1 Performing fetal surgery to correct underdeveloped lungs
2 Growing replacement blood vessels for patients in need of coronary artery bypass
3 Building a new liver to function like a human organ
4 Assisting transplant recovery
5 Researching regenerative therapies for spinal cord injuries
6 Engineering cells to regenerate heart tissue
.."Regenerative Medicine Minnesota is one of the most important investments Minnesota has made in the health care of our citizens.
https://newsnetwork.mayoclinic.org/discussion/6-firsts-in-advancing-regenerative-medicine-toward-patient-care/
Swedish Regenerative Medicine Services
Regenerative medicine is an emerging branch of medicine that uses cell therapies to create living, functional tissues to repair or replace tissue or organ function lost due to age, disease, damage or congenital defects. Regenerative medicine is being used to pioneer new treatments in the care of heart, liver, pancreatic, lung and many other conditions.
https://www.swedish.org/services/regenerative-medicine
$LAHO GSCG TRILLION DOLLAR MARKET, EACH SEGEMENT VALUED IN THE BILLIONS$$ IF 1% OF TRILLION OR BILLION DOLLAR MARKET IS ALLOCATED TO GSCG THE UPSIDE IS ENORMOUS, THEN BLOCKCHAIN??$$$$$$$$$
$LAHO Benito Novas & GSCG WISHES TO COMPLETE MERGER
CES University of Medelln, Colombia bestowed the honor upon Novas due to his exemplary work in marketing and the regenerative medicine field.
awarded the degree of Dr. Honoris Causa from CES University in Medellín.
Novas has also played an integral role in the regenerative medicine field as a business owner. His contributions to the field are noteworthy and include organizing various congresses and certification courses across five continents. His holding, the Global Stem Cells Group, has worked to increase access to affordable equipment and regenerative medicine supplies to doctors across the world. His foundation has provided hundreds of free regenerative medicine treatments in each country where he has visited.
https://www.nbc29.com/story/40587840/global-stem-cells-groups-benito-novas-named-dr-honoris-causa
http://www.stemcellsgroup.com/author/bnovas/
Benito, GSCG & Lans Holding wish to complete merger!!
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
TAGGED UNDER:
GLOBAL AND LAHO, GLOBAL STEM CELLS GROUP, GLOBAL STEM CELLS GROUP NETWORK, GOOD MANUFACTURING PRACTICE, ISSCA, LAHO, LANS HOLDINGS
http://www.stemcellsgroup.com/lans-holdings-extension-to-complete-acquisition-of-gscg/
For an uncomplicated reporting company audited by a “Big Five” firm,1
..1 An example that we identified at random was a reporting company under section 12(g) of the Exchange Act that manufactures high-technology equipment for medical, scientific, and research applications. Its stock is quoted for less than $0.50 per share..
Sam Scott Miller, Esq.
Orrick, Herrington & Sutcliffe LLP
https://www.finra.org/sites/default/files/notice_comment_file_ref/Comments%20to%20211%20Repository%20%28FINAL%29_0.pdf
$LAHO GSCG FUTURE OF MEDICINE$$$$$$$$$$GSCG audit & LEGAL team, a perfect match-scenario in Finra’s rule testing methodology “uncomplicated” or fast track Medical and future of medicine$$$
$LAHO..GSCG RM..Goldman Conservative $600 Billion..BOFA, Trillion-Dollar Longevity Industry..
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
180-day extension to complete the acquisition of 100% of Global Stem Cells Group Inc (GSCG)...The Company intends to now file a form 10 to reregister its common shares with the SEC and to locate a market maker to sponsor the Company in a 211 filing to reinstate trading of the Company’s shares.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1432518
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
Benito, GSCG & Lans Holding wish to complete merger!!
https://www.facebook.com/globalstemcells/?hc_ref=ARSj4BCjfAFJ509qmIEBOfxVf_mpY6qYHomlX6pqzzt3stUM2qX-lPjUiwuB1tjVpv8&__xts__[0]=68.ARA1RyWVaB2UqFWYY_XIpNzoE5JPm2e-xbBOX7gNoqTkWziTXrLcKqEpk043qO7eo5hz3nO2j-uKnaXDbHQ_hc_1lsbk0y-Yv2gvONC4gViO-T82x9MYD2R_7YICd7AI2dqZa_OmcxwMKuViFc9kD7EVBWIIrBvAcYuVY6nEqS0z0xZKZm-tGpLdEFNr7EB4IcnGbD49_Fm0mH82sJ5ZB4zZs6KGXM2zx-Kz2NHVFNp8HYu6X2NIJuJOVEk4UUTCF5qMO_Q5XOGaqKUyBnwE6ipbe3Ys4xX_gLnqWB1QAvvEu6FtMIJZUA_8uvfx2N1BWJnZOmVoJxowcio4BqOVp7eEcP_RaqeH1i3PrwkU30dQ2IHZ8aHjYGR3H_GDcQuX69isDNYZhxgWcy-ZqgbSjQbIF3UI5ZRQ6Vzh3XlgjbS1_Zk&__tn__=kC-R
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
The Trillion-Dollar Longevity Industry
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://www.inc.com/james-paine/3-industries-that-will-probably-create-the-first-trillionaire.html
https://www.nanalyze.com/2019/08/top-10-companies-longevity
US health..spending increased 5.8%..3.2 Trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Supplier N-Biotek $8.4M
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies..
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
http://stemcellcenter.net/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
NEW CLINICAL TRIAL ONCE AGAIN.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
$LAHO Much appreciated, followed back.
Welcome to the Global Stem Cells Group website! GSCG is a group of companies, each dedicated to facilitating stem cell research and medicine.
Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
http://www.stemcellsgroup.com/our-story/
GSCG QATAR
GSCG Costa Rica
GSGC CHILE & ARGENTINA
GSGC MEXICO
SOUTH KOREA
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
https://twitter.com/StemCellGroupUS
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
https://nyscf.org/wp-content/uploads/2008/03/3-13-08%20nysd%20-%20sls.pdf
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, [b[color=red]]it’s valued at a staggering $12 billion[/color]. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$LAHO Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
These are the students Goldman Sachs REALLY wants to hire
..37% of the analysts hired by Goldman Sachs last year were STEM majors according to Blankfein.
https://news.efinancialcareers.com/uk-en/273366/goldman-sachs-stem-students
https://www.goldmansachs.com/search/search.gscgi?query=STEM+CELLS
Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer
https://www.prnewswire.com/news-releases/cancer-biotech-firm-alpha-tau-medical-appoints-raphi-levy-of-goldman-sachs-as-chief-financial-officer-300818388.html
Lloyd Blankfein, the CEO of Goldman Sachs, announced on Tuesday that he has lymphoma..Stem cell transplantation could also be used as a treatment.
https://fortune.com/2015/09/22/lymphoma/
https://www.issca.us/
http://stemcellcenter.net/center/quito/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
Stem cells are the clearest opportunity to provide humans with a potentially life-saving solution in the future..Furthermore, the combination of private and public healthcare is the subject of current research, as is the development of new solutions and therapies...
Today, stem cells..are routinely used to treat approximately 80 medical conditions including leukaemia, lymphoma, immune disorders and anaemia. However, affordability and accessibility remain a challenge.
https://www.europeanceo.com/business-and-management/how-stem-cell-treatments-can-make-medicine-effective-and-affordable/
Have there been improvements in Alzheimer's disease drug discovery over the past 5 years?
Alzheimer's disease (AD) is the most important neurodegenerative disorder with a global cost worldwide of over $700 billion
Expert opinion: Unsuccessful outcomes in AD therapeutics are attributed to pathogenic misconceptions, erratic procedures in drug development and inappropriate regulations.
https://www.ncbi.nlm.nih.gov/m/pubmed/29607687/
Medical Tourism Market Worth $179.6 Billion By 2026 CAGR: 21.9%
https://www.grandviewresearch.com/press-release/global-medical-tourism-market
Stem cells: Creating a cure-all
..Stem cells harvested here can help patients with sickle-cell disease and leukaemia.
https://www.nature.com/articles/515S14a
Treatments for eye diseases are considered among the most promising for stem cells, which have been under study for more than 3 decades. While proponents say all this groundwork is finally coming to fruition, others call progress slow and plodding.
.."I would say the pace of things has been much faster than I would have predicted," says Andy McMahon, PhD, a W.M. Keck provost and university professor at the University of Southern California.
In comparison, Wells says, prescription drugs often take 15 years to progress from research stages to market.
https://www.webmd.com/brain/news/20190812/stem-cells-and-health-advances-where-are-we-now
US health..spending increased 5.8%..3.2 Trillion
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Cancer Reversion
Despite spending close to a trillion dollars in the “war on cancer” to date, the disease remains one of our major killers.
Organ Repair/Regeneration
Over $60 billion in care annually is spent on these patients, when only taking into account the costs of dialysis and kidney transplants
www.bioquark.com/bioquantine-programs/bq-a-clinical-plans/
At current rates, by 2025, nearly ¼ of the US GDP will be spent on healthcare.
It takes on average 12 years and $359 million to take a new drug from the lab to a patient.
Only 5 in 5,000 of these new drugs make it to human testing. From there, only 1 of those 5 is actually approved for human use.
And Now, the Good News:
We are in the midst of a (medical) revolution driven by exponential technology: artificial intelligence, sensors, robotics, 3D printing, big data, genomics and stem cells.
Today’s $3.8 trillion dollar healthcare industry is in the deceptive phase of its march towards dematerialization, demonetization and democratization (as I discuss in my A360 Summits).
Stem Cells:
We are now in the earliest stages of stem cell therapy development. Future therapies will be transformative and, frankly, mind-boggling.
Stem cell therapy promises tissue regeneration and renewal – and thus a “cure” for everything from blindness to spinal cord injuries, type 1 diabetes, Parkinson’s disease, Alzheimer’s disease, heart disease, stroke, burns, cancer and osteoarthritis.
In 2012, researchers at Cedars-Sinai reported one of the first cases of successful therapeutic stem cell treatment – they used patients’ own stem cells to regenerate heart tissue and undo damage from a heart attack.
https://www.diamandis.com/blog/life-or-death
$17.3 Bn Stem Cell Banking Market - Global Industry..CAGR of 13.5%
https://www.prnewswire.com/news-releases/17-3-bn-stem-cell-banking-market---global-industry-trends-share-size-growth-opportunity-and-forecast-2019-2024--300816982.html
Ophthalmologic stem cell transplantation therapies
The annual direct cost of medical care for the most prevalent eye disease, age-related macular degeneration, was estimated at US $255 billion in 2010 with an additional economic impact of US $88 billion due to lost productivity and the burden of family and community care for visual disability.
..demonstrate that stem cell-based transplants can preserve and potentially improve vision. This has led to new clinical trials for several eye diseases that are yielding encouraging results. In the next few years, additional trials and longer-term results are anticipated to further develop ocular regenerative therapies, with the potential to revolutionize our approach to ophthalmic disease and damage.
https://www.futuremedicine.com/doi/10.2217/rme.12.77
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Ophthalmologic therapies $343b
4 Tourism $179B
5 Organ repair $60B
6 3D printers $30B
7 Stem Bank $17.3B
8 Knee replacement?
9 ?
10 ?
$GSCG The future of Medicine, each sector worth Billions, printers, cosmetic, therapy, marketing, tourism, medical devices. Billions of dollars from big pharm will find the route to regenerative care. Best to measure against the market as seen fit$$$
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The power to print money.
Trillions of dollars – on-demand.[/color]
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market!
China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
https://orders.thecrux.com/chain?cid=MKT376375&eid=MKT417624&step=start&assetId=AST90728&page=1
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150726448
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
In 2018, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market..
https://www.globenewswire.com/news-release/2019/07/16/1883226/0/en/Global-Cell-Culture-Market-Outlook-Report-2019-2024-Pharmaceutical-Biotechnology-Companies-are-Expected-to-Dominate.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
Transplanted cells offer middle-aged rodents an increased life span
https://www.scientificamerican.com/article/brains-stem-cells-slow-aging-in-mice/
Bone Marrow Transplants Increase Healthy Lifespan in Mice
Stem Cell Start-up Could Extend Lifespan by Decades
Will 100 be the new 60?
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
..The new biotech initiative whose board includes former Apple CEO John Sculley, ex-FDA commissioner Andrew Von Eschenbach and founder of Alphabet’s venture capital arm Bill Maris, is built around the idea that stem cells found in postpartum human placentas are ideal for regenerating damaged and aged tissue
https://wallstreetpit.com/114544-stem-cell-extend-lifespan-decades/
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO..US health..spending increased 5.8% to..USD 3.2 Trillion trillion which is also expected to impel the growth of stem Cell and regenerative medicine market in the North America. U.S. is the prominent market driving the growth in the region.
..North America is slated to account for a leading share of 39.7% by 2024 in the stem cell and regenerative medicine market. The growth in the region can be attributed to presence of well-established healthcare industry along with expanded funding from the governments organizations.
https://www.prnewswire.com/news-releases/global-stem-cell-and-regenerative-medicine-market-demand-analysis--opportunity-report-2018-market-is-expected-to-garner-usd-14-74-billion-by-the-end-of-2024--300735187.html
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
Venture capital investments..record.. $207 billion
https://singularityhub.com/2019/08/20/these-are-the-meta-trends-shaping-the-future-at-breakneck-speed/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Stem Cells Lead To A Genuine Miracle Cure
Exosomes, metastases, and the miracle of cancer stem cell markers
https://www.ncbi.nlm.nih.gov/pubmed/31030373
Stem Cell Treatment Could Be a Game-Changer for People With MS
https://time.com/5205946/stem-cell-treatment-multiple-sclerosis-patients/
On the immortality of stem cells
University of Cologne
Summary: Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D..worth over $30 billion by 2022
https://investingnews.com/daily/tech-investing/3d-printing-investing/top-3d-printing-companies/
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://www.linkedin.com/company/lans-holdings-inc
https://www.linkedin.com/in/dave-christensen-b38a82
http://www.lans.holdings
https://www.linkedin.com/company/tnt-blockchain
$1.37 per share..TNT Blockchain is led by President David Christensen
https://www.zkinternationalgroup.com/xsigma-corporation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
BENITO'S FRIENDS AND PARTNERS WELL CONNECTED.
..OXFORD Stem cell biologist interested in tissue regeneration. Also, Lyme disease and its complications
..Microcap telemedicine provider Telemynd sets terms for $8 million IPO
..IGM Biosciences ups IPO share offering by 40% as insiders indicate on additional $50 million
https://www.nasdaq.com/market-activity/ipos/overview?dealId=1048506-87910
$LAHO MAYO CLINIC AND BIOHEART CELL INFUSION DEVICES FORCARDIOVASCULAR THERAPY AND GSCG CLINICAL TRIAL
MyoCath, Bioheart Inc
https://www.mayoclinicproceedings.org/article/S0025-6196(13)00928-2/fulltext
https://www.mayoclinicproceedings.org/article/S0025-6196(13)00928-2/pdf
LATIN AMERICA
https://www.prnewswire.com/news-releases/bioheart-announces-cell-therapies-program-in-latin-america-for-congestive-heart-failure-and-peripheral-arterial-disease-patients-88949077.html
Global Stem Cells Group, Inc. And Bioheart, Inc. Launch Clinical Trial For COPD Stem Cell Therapies
https://www.biospace.com/article/releases/-b-global-stem-cells-group-inc-b-and-bioheart-inc-launch-clinical-trial-for-copd-stem-cell-therapies-/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
BENITO GLOBAL TRAVELS-PARTNERS FROM Kuwait TO CHILE
Medicel Stem Cell Laboratory Visit Santiago Chile
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile
http://adimarket.info/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
VidaCel Chile.
Stem Cells May Repair "Irreversible" Heart Damage
https://www.forbes.com/sites/stevensalzberg/2014/05/05/stem-cells-may-repair-irreversible-heart-damage/#4a1b7ce46033
Blankfein, Goldman Partners Hit Hamptons for Stem Cell Event
https://www.bloomberg.com/news/articles/2016-07-19/blankfein-goldman-partners-hit-hamptons-for-stem-cell-benefit
1 Cancer $1 Trillion
2 Alzheimer's disease $700B
3 Tourism $179
4 Organ repair $60B
5 3D printers $30b
6 Stem Bank $17.3B
7 Cell Culture Media $1.2B
8 Knee replacement?
9 ?
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH. GOLDMAN SACH'S, BILLIONAIRES PURING MONEY INTO STEM CELLS. GSCG.. EACH DIVISION OF GSCG COULD RUN TO PENNIES..COMBINED?
QUOD ERAT DEMONSTRANDUM GLTA
|
Followers
|
16
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
179
|
|
Created
|
09/18/19
|
Type
|
Free
|
| Moderators | |||
